
China NT Pharma Group to Acquire 100% Stake in Target Companies

I'm PortAI, I can summarize articles.
China NT Pharma Group Company Limited is acquiring 100% of the issued shares in several target companies for RMB116,219,960. The acquisition involves the issuance of consideration shares under a specific mandate and is governed by a sale and purchase agreement dated April 28, 2025. The original content was published by China NT Pharma Group via the Hong Kong Stock Exchange's Issuer Information Service on December 24, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

